Vivace Therapeutics
2014
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Series B
LATEST DEAL TYPE
$25M
LATEST DEAL AMOUNT
5
INVESTORS
Description
Provider of a novel targeted cancer therapy. The company is engaged in targeting novel pathway for the treatment of cancer.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 2929 Campus Drive
- Suite 405
- San Mateo, CA 94403
- United States
+1 (858) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Vivace Therapeutics’s full profile, request a free trial.
Vivace Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series B) | 28-Jun-2017 | $25M | 0000 | 0000 | Completed | Startup |
| 1. Early Stage VC (Series A) | 20-Jan-2015 | 0000 | 0000 | 0000 | Completed | Startup |
Vivace Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A | 00,000,000 | 00.000000 | 00.00 | 00 | 00 | 00 | 00 | 00.000 |
Vivace Therapeutics Competitors (29)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Immatics | Venture Capital-Backed | Tübingen, Germany | 00 | 00000 | 00000000000 | 00000 |
| 000000000 | Private Equity-Backed | Camarillo, CA | 00 | 000 | 00 000000 | 000 |
| 000000000000000 | Venture Capital-Backed | Saint Louis, MO | 0 | 00.000 | 000000000 | 00.000 |
| 00000 | Venture Capital-Backed | Boston, MA | 0 | 0000 | 000 | |
| 00000000 000000000 | Angel-Backed | Pasadena, CA | 0 | 00.000 | 0000000000 | 00.000 |
Vivace Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Cenova Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Sequoia Capital China | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Canaan Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Mission Bay Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| WuXi Healthcare Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |
Vivace Therapeutics Executive Team (6)
1 Former Executive
You’re viewing 5 of 6 executives. Get the full list »Vivace Therapeutics Board Members (6)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Edward Hu | Vivace Therapeutics | Board Member | 000 0000 | |
| Jun Wu | Vivace Therapeutics | Board Member | 000 0000 | |
| Leonard Post Ph.D | Self | Chief Scientific Officer & Board Member | 000 0000 | |
| Shuang Qiao Ph.D | Self | President, Chief Executive Officer and Director | 000 0000 | |
| Tim Shannon | Vivace Therapeutics | Board Member | 000 0000 |
1 Former Board Member
You’re viewing 5 of 6 board members. Get the full list »